Skip to content

ExerciseEnhances+: A prospective cohort study on the synchronization of exercise therapy and cognitive behavioural therapy in depression

ExerciseEnhances+: A prospective cohort study on the synchronization of exercise therapy and cognitive behavioural therapy in depression - ExerciseEnhances+

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON57575
Enrollment
57
Registered
2025-01-16
Start date
2025-09-11
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression

Interventions

The 12-16 week intervention encompasses weekly supervised 45-min exercise sessions (moderate intensity aerobic exercise) followed by CBT, both in group setting. Additionally, participants are prescr

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: • Adult: age 16 + • Current diagnosis of major depressive disorder, based on the Structured  Clinical Interview for DSM-5 (SCID-5-S)(First et al., 1998) flanked with  clinical judgement. 

Exclusion criteria

Exclusion criteria: • Impossibility to obtain a valid informed consent • Physical, cognitive, or intellectual impairments interfering with participation • High health risks of physical activity (determined by clinician and/or assessed using the Physical Activity Readiness Questionnaire; Shephard et al., 1981) • Lifetime manic episode • Insufficient comprehension of Dutch language • Current admission to treatment centre

Design outcomes

Primary

MeasureTime frame
The primary endpoint is clinical improvement (decreases in depressive symptoms and improved CBT skills) from baseline to post-treatment measured weekly, and to 3-month follow-up.

Secondary

MeasureTime frame
Secondary parameters are physical activity, mood states, emotional autobiographical memory, energy, motivation, biomarker levels of endocannabinoids and brain-derived neurotropic factor, genetics, and daily functioning.

Countries

Netherlands

Contacts

Public ContactJ Vrijsen

Radboud Universitair Medisch Centrum

janna.vrijsen@radboudumc.nl0243610685

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Apr 17, 2026